|
FAM111A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
4.77189999958938E-07 |
| Normal-vs-Stage3 |
7.36855021443716E-13 |
| Normal-vs-Stage4 |
3.41920047830513E-10 |
| Stage1-vs-Stage2 |
6.876200E-01 |
| Stage1-vs-Stage3 |
2.096400E-01 |
| Stage1-vs-Stage4 |
3.261600E-01 |
| Stage2-vs-Stage3 |
6.310600E-01 |
| Stage2-vs-Stage4 |
7.104400E-01 |
| Stage3-vs-Stage4 |
9.070200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.98900000003555E-06 |
| Normal-vs-Asian |
4.261300E-03 |
| Caucasian-vs-AfricanAmerican |
3.438400E-01 |
| Caucasian-vs-Asian |
3.545000E-01 |
| AfricanAmerican-vs-Asian |
1.424410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.798400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.302900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(81-100Yrs) |
2.295300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.019400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.194000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.465400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.600300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.253600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.232400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.638500E-04 |
| Normal-vs-Grade 2 |
1.62458935193399E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
7.80759999985392E-08 |
| Grade 1-vs-Grade 2 |
4.925400E-01 |
| Grade 1-vs-Grade 3 |
6.446200E-01 |
| Grade 1-vs-Grade 4 |
2.952200E-01 |
| Grade 2-vs-Grade 3 |
4.965000E-01 |
| Grade 2-vs-Grade 4 |
5.400600E-01 |
| Grade 3-vs-Grade 4 |
2.615000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
9.86349890652605E-11 |
| ccA subtype-vs-ccB subtype |
1.988450E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.959950E-02 |
| N0-vs-N1 |
8.156600E-01 |
|
|
